Article Details

Morphic (NASDAQ:MORF) Earns Buy Rating from BMO Capital Markets - Defense World

Retrieved on: 2022-08-08 22:14:08

Tags for this article:

Click the tags to see associated articles and topics

Morphic (NASDAQ:MORF) Earns Buy Rating from BMO Capital Markets - Defense World. View article details on hiswai:

Excerpt

BMO Capital Markets currently has a $83.00 price target on the stock. Other equities analysts have also recently issued research reports about the ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up